Battling COVID-19: using old weapons for a new enemy

Tropical Diseases, Travel Medicine and Vaccines

Nitin Gupta¹  Ankit Mittal²  Manish Soneja²  Rohit Kumar²  Naveet Wig²  Parul Kodan³ 

[1] Department of Infectious Diseases, Kasturba Medical College;Department of Medicine, All India Institute of Medical Sciences;Dr Ram Manohar Lohia hospital & Post-Graduate Institute of Medica education and Research;

关键词: SARS-CoV-2;    Hydroxychloroquine;    Lopinavir/ritonavir;    Remdisivir;    Nitazoxanide;    Tocilizumab;   

DOI  :  10.1186/s40794-020-00107-1

来源: DOAJ

【 摘 要 】

Abstract Coronavirus disease-19 (COVID-19) has reached pandemic proportions. Most of the drugs that are being tried for the treatment have not been evaluated in any randomized controlled trials. The purpose of this review was to summarize the in-vitro and in-vivo efficacy of these drugs on Severe Acute Respiratory Syndrome (SARS-CoV-2) and related viruses (SARS and Middle East Respiratory Syndrome) and evaluate their potential for re-purposing them in the management of COVID-19.

【 授权许可】

Unknown